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Amyloid-beta peptide induces time dependent biphasic change of 
membrane phase properties in DITNC cells 
Jacob Hicks, Yinzhi Lai, & James Lee 
 
Amyloid-beta peptide (A&beta;) has been widely implicated in the pathogenesis of 
Alzheimer's disease (AD). In AD patients amyloid plaques accumulate extensively in 
the brain, a pathological archetype of the disease. To elucidate one pathway that 
contributes to AD dysfunction, we demonstrate that oligomeric A&beta;1-42 alters 
the membrane phase properties of DITNC cells time-dependently, with the phase 
change made quantifiable through fluorescence microscopy and GP analysis. 
Initially, after oligomeric A&beta;1-42 treatment the phase properties became more 
liquid-crystalline, and subsequently, after 2-3 hours the phase became more gel-
like. However, in lipid vesicles the change in membrane phase properties wasn't 
biphasic; the phase became only more liquid-crystalline, indicating the role of cell 
signaling in the phenomenon. Western blot analysis demonstrated the ability of 
oligomeric A&beta;1-42 to increase levels of phosphorylated cPLA2 on a time scale 
corresponding to the observed change in membrane phase, implicating cPLA2 as a 
likely contributor to the liquid-crystalline to gel transition, with its activation and 
translocation to the membrane likely the cause of the specific time frame 
associated with the liquid-crystalline to gel transition. Co-treatment of oligomeric 
A&beta;1-42 with MAFP, an inhibitor of iPLA2 and cPLA2 caused the membrane to 
become only more liquid crystalline, while oligomeric A&beta;1-42 + BEL, a specific 
inhibitor of iPLA2, resulted in the previously observed biphasic transition, 
eliminating iPLA2 as a contributor to the phenomenon. Additionally, A&beta;1-42 + 
Apocynine, an antioxidant, caused the membrane to become only more liquid 
crystalline, which more specifically revealed oligomeric A&beta;1-42 triggers the 
activation of cPLA2 through ROS generation, likely through NADPH oxidase, 
activating the MAPK cascade. Evaluating the effect of oligomeric A&beta;1-42 on 
membrane phase properties provides a different view of a widely implicated 
pathogen in AD, revealing that it acts both to immediately cause the membrane to 
become more liquid-crystalline, while triggering cPLA2 to change the membrane 
phase to gel-like over time. 
 
